MET Inhibitors for the Treatment of Gastric Cancer: What's Their | JEP
MET amplified gastric cells undergo apoptosis when exposed to... | Download Scientific Diagram
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
![TP53 mutation and MET amplification in circulating tumor DNA analysis predict disease progression in patients with advanced gastric cancer [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2021/11146/1/fig-4-1x.jpg "TP53 mutation and MET amplification in circulating tumor DNA analysis predict disease progression in patients with advanced gastric cancer [PeerJ]")
TP53 mutation and MET amplification in circulating tumor DNA analysis predict disease progression in patients with advanced gastric cancer [PeerJ]
Prevalence of MET amplification and increased MET gene copy number... | Download Table
Selective killing of gastric cancer cell lines with MET amplification... | Download Scientific Diagram
Comprehensive analyses using next-generation sequencing and immunohistochemistry enable precise treatment in advanced gastric cancer - Annals of Oncology
The multiple paths towards MET receptor addiction in cancer | Oncogene
Targeting MET in Cancer: Obstacles and Potentials | Insight Medical Publishing
The Right Treatment of the Right Patient: Integrating Genetic Profiling Into Clinical Decision Making in Advanced Gastric Cancer in Asia | American Society of Clinical Oncology Educational Book
Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752 | PNAS
MET-dependent solid tumours — molecular diagnosis and targeted therapy | Nature Reviews Clinical Oncology
A first-in-human phase I study of SAR125844, a selective MET tyrosine kinase inhibitor, in patients with advanced solid tumours with MET amplification - European Journal of Cancer
Table 1 from Amplification MET ( PF-02341066 ) in Gastric Cancer Positive for Antitumor Action of the MET Tyrosine Kinase Inhibitor Crizotinib | Semantic Scholar
PLOS ONE: Prognostic Significance of MET Amplification and Expression in Gastric Cancer: A Systematic Review with Meta-Analysis
PLOS ONE: Prognostic Significance of MET Amplification and Expression in Gastric Cancer: A Systematic Review with Meta-Analysis
Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification | BMC Cancer | Full Text
Amplification of MET in gastric cancer cell lines. A, FISH analysis of... | Download Scientific Diagram
Increased HGF Expression Induces Resistance to c-MET Tyrosine Kinase Inhibitors in Gastric Cancer | Anticancer Research
KEGG PATHWAY: Gastric cancer - Homo sapiens (human)
Cancers | Free Full-Text | Molecular Targets for Gastric Cancer Treatment and Future Perspectives from a Clinical and Translational Point of View | HTML
MET Inhibitors for the Treatment of Gastric Cancer: What's Their | JEP
